The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

Weight loss jabs, also known as GLP-1 receptor agonists and sold under brand names like Mounjaro and Wegovy, work by reducing ...

TikTok creator Janelle Rohner revealed she is taking a GLP-1 medication for weight loss — despite selling $200 courses to ...

A study from the New England Journal of Medicine found new evidence that GLP-1 drugs used for diabetes and obesity could also ...

Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep medicine.

While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...

Though retrospective, the findings provide ‘compelling’ evidence that GLP-1 receptor agonists may help prevent development ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Get your weekly dose of the top news that matters in our newsletter.

Shares in Hims & Hers Health soared in early-morning trading after it announced a partnership with Wegovy maker Novo Nordisk.

Health and wellness influencer Janelle Rohner had been documenting her weight loss journey long before she admitted to using ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.